• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Objective Data to Inform Weight Gain Recommendations for Pregnant Women with Obesity

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Weight gain in excess of current guidelines occurs in 2 out of every 3 pregnancies among women with obesity
  • IOM recommends all pregnant women increase energy intake by 340–450 kcal/d during the second and third trimesters
  • ACOG acknowledges that obese women may benefit from fewer calories, but no clear guidance is given regarding precise intake
  • Most et al. (Journal of Clinical Investigation, 2019) studied energy expediture in women with obesity

METHODS:

  • Prospective, observational study
  • Participants
    • Pregnant women with obesity (BMI ≥ 30 kg/m2 at ≤15 weeks)
  • Study design
    • Energy intake was calculated by the energy intake-balance method
    • Energy expenditure in early (13–16 weeks) and late (35–37 weeks) pregnancy was measured by
      • Doubly labeled water
      • Whole-room indirect calorimetry
      • Body composition as a 3-compartment model by air displacement plethysmography
      • Isotope dilution
  • Women were grouped in to the following categories
    • Achieved the recommended IOM weight gain: ≥170 g/week to <270 g/week (0.4 to 0.6 lb/week)
    • Excess weight gain: ≥270 g/week
    • Inadequate weight gain: <170 g/week  
  • Primary outcomes
    • Energy intake | Energy expenditure | Energy deposition

RESULTS:

  • 54 women participated
    • Achieved the recommended IOM weight gain: 15%
      • Energy intake was 125 ± 52 kcal/d less than energy expenditure (i.e. negative energy intake was required to meet the guideline)
    •  Excess weight gain (≥270 g/week): 67%
      • 186 ± 29 kcal/d more than they expended (P < 0.001)
    • Inadequate weight gain (<170 g/week): 19%
      • Inadequate gain was found more often in group with more severe obesity
  • No difference in pregnancy outcomes, delivery outcomes, and birth weight among the 3 groups
  • Weight gain was not related to
    • Demographics
    • Activity
    • Metabolic biomarkers
    • Diet quality

CONCLUSION:

  • This study may be the first to provide the necessary evidence to set energy intake requirements for pregnant women with obesity
  • The authors disagree with current IOM guidance that would lead women with obesity to increase energy intake later in pregnancy
    • An energy deficit of approximately 100 kcal/d is required to meet the recommended IOM weight gain recommendations of 0.4 to 0.6 lbs per week
  • The authors conclude that

…recommended rate of weight gain was achieved by the gain of fat-free mass alone (e.g., fetus, uterus, blood volume, breast tissue)

…this study challenges current practice and argues that women with obesity should not be advised to consume additional energy during pregnancy as currently recommended.

Learn More – Primary Sources:

Evidence-based recommendations for energy intake in pregnant women with obesity

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Learn More  »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Practical obstetrics info for your women's healthcare practice
Recommended Weight Gain and Obesity Management in Pregnancy
Is There an Association Between High or Low Weight Gain and Maternal and Infant Outcomes?
Can a Smartphone ‘Diet and Activity’ App Impact Gestational Weight Gain?
Does Lifestyle Intervention Ameliorate Pregnancy Weight Gain and Does It Affect Perinatal Outcomes?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site